US20020022056A1
(en)
|
1997-02-14 |
2002-02-21 |
Burkhard Schlutermann |
Oxacarbazepine film-coated tablets
|
US20040185095A1
(en)
*
|
2002-05-31 |
2004-09-23 |
Hanshermann Franke |
Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
|
WO2004014391A1
(en)
*
|
2002-08-06 |
2004-02-19 |
Novartis Ag |
Use of carboxamides for the treatment of tinnitus
|
GB0221956D0
(en)
*
|
2002-09-20 |
2002-10-30 |
Novartis Ag |
Organic compounds
|
WO2005020968A2
(en)
*
|
2003-09-03 |
2005-03-10 |
Novartis Ag |
Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
|
AR048672A1
(es)
*
|
2004-03-22 |
2006-05-17 |
Novartis Ag |
Tabletas de desintegracion que comprenden licarbazepina
|
US20090196919A1
(en)
*
|
2004-10-25 |
2009-08-06 |
Ajay Singla |
Oxcarbazepine dosage forms
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
US20090143360A1
(en)
*
|
2005-07-08 |
2009-06-04 |
Muhammed Safadi |
Oxcarbazepine Formulation
|
WO2007029093A2
(en)
*
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Pharmaceutical dosage forms of oxcarbazepine
|
WO2007089247A1
(en)
*
|
2006-01-31 |
2007-08-09 |
Teva Pharmaceutical Industries Ltd. |
Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
|
JP2008540346A
(ja)
*
|
2006-01-31 |
2008-11-20 |
テバ ファーマシューティカル インダストリーズ リミティド |
オキシカルバゼピンの医薬製剤及びその調製方法
|
ATE496623T1
(de)
*
|
2006-04-26 |
2011-02-15 |
Supernus Pharmaceuticals Inc |
Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
|
US20080138403A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Sun Pharmaceutical Industries Ltd. |
Pharmaceutical dosage forms of oxcarbazepine
|
GB0700773D0
(en)
|
2007-01-15 |
2007-02-21 |
Portela & Ca Sa |
Drug therapies
|
EP2918578A1
(en)
|
2007-03-16 |
2015-09-16 |
Concert Pharmaceuticals, Inc. |
Inhibitors of cholesterol ester transfer protein
|
WO2008128166A1
(en)
*
|
2007-04-13 |
2008-10-23 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
|
CN101687824A
(zh)
*
|
2007-04-19 |
2010-03-31 |
康塞特医药品公司 |
氘化吗啉基化合物
|
EP2152689B1
(en)
|
2007-04-25 |
2013-01-02 |
Concert Pharmaceuticals Inc. |
Analogues of cilostazol
|
BRPI0811478B8
(pt)
|
2007-05-01 |
2021-05-25 |
Concert Pharmaceuticals Inc |
compostos de morfinano, composição contendo os ditos compostos, usos dos mesmos, embalagem e formas de dosagem separadas
|
MX341177B
(es)
|
2007-05-01 |
2016-08-10 |
Concert Pharmaceuticals Inc |
Compuestos de morfina.
|
PL2522668T3
(pl)
|
2007-05-01 |
2015-07-31 |
Concert Pharmaceuticals Inc |
Związki morfinanu
|
CA2685924A1
(en)
|
2007-05-01 |
2008-11-13 |
Concert Pharmaceuticals Inc. |
Naphthyl(ethyl)acetamides
|
MX2009013565A
(es)
|
2007-06-12 |
2010-06-02 |
Concert Pharmaceuticals Inc |
Derivados de azapeptidos.
|
WO2009051782A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
WO2009108383A2
(en)
|
2008-02-29 |
2009-09-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
US20110160253A1
(en)
*
|
2008-05-28 |
2011-06-30 |
Harbeson Scott L |
Deuterated tizanidine
|
US20100221221A1
(en)
*
|
2008-08-12 |
2010-09-02 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
MX361542B
(es)
|
2008-09-19 |
2018-12-10 |
Concert Pharmaceuticals Inc |
Compuestos de morfinan.
|
PL2397158T3
(pl)
|
2008-10-30 |
2016-09-30 |
|
Skojarzone podawanie związków morfinanów oraz leków przeciwdepresyjnych w leczeniu nietrzymania afektu
|
US20120053169A1
(en)
|
2008-10-30 |
2012-03-01 |
Amanda Thomas |
Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
|
CN102202678A
(zh)
|
2008-11-04 |
2011-09-28 |
安科治疗公司 |
Cxcr4受体化合物
|
WO2010065755A1
(en)
|
2008-12-04 |
2010-06-10 |
Concert Pharmaceuticals, Inc. |
Deuterated pyridinones
|
US20110053961A1
(en)
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
AP2909A
(en)
|
2009-03-17 |
2014-05-31 |
Concert Pharmaceuticals Inc |
Pyrazinoisoquinoline Compounds
|
WO2010138889A1
(en)
|
2009-05-28 |
2010-12-02 |
Concert Pharmaceuticals, Inc. |
Peptides for the treatment of hcv infections
|
WO2011005520A1
(en)
|
2009-06-23 |
2011-01-13 |
Concert Pharmaceuticals, Inc. |
Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
|
US20110015154A1
(en)
*
|
2009-07-20 |
2011-01-20 |
Kellermann Gottfried H |
Supporting acetylcholine function
|
US8278460B2
(en)
|
2009-10-15 |
2012-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
US20110098265A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Neuroscience, Inc. |
Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
|
WO2011060216A1
(en)
|
2009-11-12 |
2011-05-19 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
WO2011103457A1
(en)
|
2010-02-18 |
2011-08-25 |
Concert Pharmaceuticals Inc. |
Pyrimidine derivatives
|
US9155795B2
(en)
|
2010-02-26 |
2015-10-13 |
Anchor Therapeutics, Inc. |
CXCR4 receptor compounds
|
US8513434B2
(en)
|
2010-03-02 |
2013-08-20 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
WO2012037060A1
(en)
|
2010-09-13 |
2012-03-22 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
WO2012065028A2
(en)
|
2010-11-11 |
2012-05-18 |
Concert Pharmaceuticals Inc. |
Substituted tetracyclines
|
WO2012079075A1
(en)
|
2010-12-10 |
2012-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated phthalimide derivatives
|
US8447329B2
(en)
|
2011-02-08 |
2013-05-21 |
Longsand Limited |
Method for spatially-accurate location of a device using audio-visual information
|
CA2828251A1
(en)
|
2011-02-25 |
2012-08-30 |
Concert Pharmaceuticals, Inc. |
2-amino-naphthyridine derivatives
|
WO2012129381A1
(en)
|
2011-03-22 |
2012-09-27 |
Concert Pharmaceuticals Inc. |
Deuterated preladenant
|
WO2012151361A1
(en)
|
2011-05-03 |
2012-11-08 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
US20140128469A1
(en)
|
2011-05-10 |
2014-05-08 |
Concert Pharmaceuticals Inc. |
Deuterated n-butyl bumetanide
|
PL2709986T3
(pl)
|
2011-05-18 |
2017-09-29 |
Concert Pharmaceuticals Inc. |
Deuterowane pochodne iwakaftoru
|
US20140296263A1
(en)
|
2011-07-19 |
2014-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
CA2860740A1
(en)
|
2012-01-09 |
2013-07-18 |
Anchor Therapeutics, Inc. |
Apj receptor compounds
|
WO2013130849A1
(en)
|
2012-02-29 |
2013-09-06 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
CN104364255A
(zh)
|
2012-04-13 |
2015-02-18 |
康塞特医药品有限公司 |
取代的黄嘌呤衍生物
|
US9249093B2
(en)
|
2012-04-20 |
2016-02-02 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
EP3450434B1
(en)
|
2012-06-15 |
2021-02-24 |
CoNCERT Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
WO2014012009A1
(en)
|
2012-07-12 |
2014-01-16 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
WO2014028756A1
(en)
|
2012-08-17 |
2014-02-20 |
Concert Pharmaceuticals, Inc. |
Deuterated baricitinib
|
MY178621A
(en)
|
2012-11-19 |
2020-10-19 |
Vertex Pharmaceuticals Europe Ltd |
Deuterated cftr potentiators
|
MX2015008187A
(es)
|
2012-12-20 |
2016-02-05 |
Concert Pharmaceuticals Inc |
Inhibidores de alk deuterados.
|
ES2700989T3
(es)
|
2012-12-21 |
2019-02-20 |
Mayo Found Medical Education & Res |
Métodos y materiales para tratar estenosis de la válvula aórtica calcificada
|
WO2014110322A2
(en)
|
2013-01-11 |
2014-07-17 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
WO2014150043A1
(en)
|
2013-03-15 |
2014-09-25 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
EP3492470A1
(en)
|
2013-03-15 |
2019-06-05 |
Concert Pharmaceuticals, Inc. |
Deuterated palbociclib with improved metabolic stability
|
HU231191B1
(hu)
|
2013-04-15 |
2021-08-30 |
Szegedi Tudományegyetem |
Izotóp tartalmú morfin molekulák
|
WO2015009889A1
(en)
|
2013-07-18 |
2015-01-22 |
Concert Pharmaceuticals, Inc. |
Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
|
EP3021861A1
(en)
|
2013-07-18 |
2016-05-25 |
Anchor Therapeutics, Inc. |
Apj receptor compounds
|
WO2015031741A1
(en)
|
2013-08-30 |
2015-03-05 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of a thienotriazolodiazapine bromodomain-containing protein inhibitor
|
WO2015063670A1
(en)
*
|
2013-10-30 |
2015-05-07 |
Wockhardt Limited |
Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof
|
WO2015120393A1
(en)
|
2014-02-10 |
2015-08-13 |
Concert Pharmaceuticals, Inc. |
Substituted triazolobenzodiazepines
|
CN106456647A
(zh)
|
2014-04-18 |
2017-02-22 |
康塞特医药品有限公司 |
治疗高血糖症的方法
|
WO2015179772A1
(en)
|
2014-05-23 |
2015-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated phenylquinazolinone and phenylisoquinolinone compounds
|
WO2015188073A1
(en)
|
2014-06-06 |
2015-12-10 |
Research Triangle Institute |
Apelin receptor (apj) agonists and uses thereof
|
WO2016022955A1
(en)
|
2014-08-07 |
2016-02-11 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
WO2016061488A1
(en)
|
2014-10-17 |
2016-04-21 |
Concert Pharmaceuticals, Inc. |
Amine reuptake inhibitors
|
WO2016073545A1
(en)
|
2014-11-06 |
2016-05-12 |
Concert Pharmaceuticals, Inc. |
Phenyloxadiazole benzoic acids
|
WO2016089814A1
(en)
|
2014-12-02 |
2016-06-09 |
Concert Pharmaceuticals, Inc. |
Deuterated analogues of daclatasvir
|
WO2016105547A1
(en)
|
2014-12-24 |
2016-06-30 |
Concert Pharmaceuticals, Inc. |
Deuterated dasabuvir
|
WO2016109795A1
(en)
|
2014-12-31 |
2016-07-07 |
Concert Pharmaceuticals, Inc. |
Deuterated funapide and difluorofunapide
|
WO2016144830A1
(en)
|
2015-03-06 |
2016-09-15 |
Concert Pharmaceuticals, Inc. |
Deuterated emricasan
|
AU2016243171B2
(en)
|
2015-03-31 |
2020-10-08 |
Concert Pharmaceuticals, Inc. |
Deuterated VX-661
|
US10683305B2
(en)
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
US20180243289A1
(en)
|
2015-07-30 |
2018-08-30 |
Concert Pharmaceuticals, Inc. |
Deuterated morphinan compounds for treating agitation
|
WO2017020005A1
(en)
|
2015-07-30 |
2017-02-02 |
Concert Pharmaceuticals, Inc. |
Morphinan compounds for use in treating agitation
|
WO2017053455A1
(en)
|
2015-09-21 |
2017-03-30 |
Concert Pharmaceuticals, Inc. |
Administration of deuterated cftr potentiators
|
EP3377179B1
(en)
|
2015-11-19 |
2021-04-07 |
Concert Pharmaceuticals Inc. |
Deuterated epi-743
|
PE20190258A1
(es)
|
2015-12-09 |
2019-02-25 |
Res Triangle Inst |
Antagonistas del receptor de la apelina (apj) mejorados y usos de los mismos
|
WO2017147003A1
(en)
|
2016-02-26 |
2017-08-31 |
Novobiotic Pharmaceuticals, Llc |
Novel macrocyclic antibiotics and uses thereof
|
AU2017261286B2
(en)
|
2016-05-04 |
2023-03-23 |
Sun Pharmaceutical Industries, Inc. |
Treatment of hair loss disorders with deuterated JAK inhibitors
|
ES2925277T3
(es)
|
2016-07-04 |
2022-10-14 |
Avanir Pharmaceuticals Inc |
Métodos para la síntesis de dextrometorfano deuterado
|
JP7178341B2
(ja)
|
2016-08-01 |
2022-11-25 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
タンパク質およびペプチドの送達のための粒子
|
EP3589659A4
(en)
|
2017-02-28 |
2021-03-24 |
Mayo Foundation for Medical Education and Research |
CANCER TREATMENT COMPOUNDS AND METHODS
|
US11278025B2
(en)
|
2017-05-17 |
2022-03-22 |
The General Hospital Corporation |
Antibiotic compounds
|
CA3063953A1
(en)
|
2017-05-19 |
2018-11-22 |
Superb Wisdom Limited |
Derivatives of resiquimod
|
AU2018371784A1
(en)
|
2017-11-22 |
2020-05-28 |
Concert Pharmaceuticals, Inc. |
Deuterated analogs of D-serine and uses thereof
|
US11243207B2
(en)
|
2018-03-29 |
2022-02-08 |
Mayo Foundation For Medical Education And Research |
Assessing and treating cancer
|
WO2021236139A1
(en)
|
2020-05-21 |
2021-11-25 |
Concert Pharmaceuticals, Inc. |
Novel deuterated jak inhibitor and uses thereof
|
JP2023553253A
(ja)
|
2020-10-28 |
2023-12-21 |
サン ファーマシューティカル インダストリーズ,インコーポレイテッド |
重水素化jak阻害剤による脱毛障害の治療のためのレジメン
|
EP4384175A1
(en)
|
2021-08-11 |
2024-06-19 |
Sun Pharmaceutical Industries, Inc. |
Treatment of hair loss disorders with deuterated jak inhibitors
|
WO2023018954A1
(en)
|
2021-08-12 |
2023-02-16 |
Concert Pharmaceuticals, Inc. |
Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors
|
WO2023215520A1
(en)
|
2022-05-04 |
2023-11-09 |
Sun Pharmaceutical Industries, Inc. |
Dosage regimens for treatment with deuterated jak inhibitors
|